Indian Pregnancy & Menstrual Care Guide — Stage 2

Pre-Conception Care & Trimester 1 (Weeks 1–13)

Medical disclaimer: Educational content only, not medical advice. Sourced primarily from Indian clinical bodies — FOGSI, MoHFW/National Health Mission (NHM), Anemia Mukt Bharat (AMB), ICMR-NIN, and DIPSI — with international research used only where a genuine gap exists in Indian guidance, and clearly marked as such. Final claims should be checked against current guideline versions before publication. Anyone with concerning symptoms should contact a provider directly.

1. Pre-Conception Care — FOGSI & ICMR Framework

A. Why Timing & Preconception Folic Acid Matter

The neural tube closes by Day 28 of embryonic development — often before a woman realizes she has missed a period. Front-loading folic acid before conception dramatically reduces the incidence of neural tube defects (such as spina bifida and anencephaly).

Standard dose: 400 mcg (0.4 mg) folic acid daily, starting ideally ≥1 month before conception and continuing through at least the first trimester (WHO/FOGSI). High-risk (prior NTD-affected pregnancy, epilepsy on certain AEDs, some diabetes pathways): 5 mg/day under specialist advice — see epilepsy note below and Fertility § folic acid.

B. Preconception Chronic-Disease Optimization

Pre-existing medical conditions should be clinically optimized prior to stopping contraception:

• Diabetes Mellitus: Optimize blood sugar (aiming for target HbA1c <6.5% before conception under medical supervision) to minimize congenital malformation risks.
• Hypertension: Review antihypertensives with your doctor. Transition off ACE inhibitors and Angiotensin Receptor Blockers (ARBs) to pregnancy-safe agents (e.g., Labetalol, Methyldopa, or Nifedipine).
• Thyroid Disorders: Ensure baseline TSH is within preconception target limits (<2.5 mIU/L), as early fetal brain development relies entirely on maternal thyroid hormone.
• Epilepsy: Consult a neurologist to achieve monotherapy at the lowest effective dose and initiate higher-dose folic acid (5 mg/day) preconception.
• Autoimmune & Psychiatric Conditions: Ensure stable disease control before conception; select medications compatible with pregnancy.
• BMI Optimization: South Asian clinical cutoffs flag BMI <18.5 kg/m² as underweight and BMI ≥23.0–25.0 kg/m² as overweight/obese. Both extremes carry distinct obstetric risks (low birth weight vs. gestational diabetes/preeclampsia).

[!IMPORTANT] Medication Safety Rule: Never abruptly stop essential prescription medications (such as anti-epileptics, psychiatric medicines, or antihypertensives) simply because you plan to conceive or have just discovered a positive pregnancy test. Abrupt discontinuation can cause maternal relapse or seizures that pose greater risk to mother and fetus than managed medication. Review all drugs with your doctor to switch to pregnancy-safe alternatives.

C. Preconception Genetic & Family-History Assessment

Genetic counseling and specialized preconception evaluation should be considered when any of the following factors are present: - Previous child born with a congenital malformation, chromosomal anomaly, or developmental disability. - History of recurrent pregnancy loss (≥2 consecutive miscarriages) or unexplained stillbirth. - Family history of inherited genetic disorders (such as Thalassemia Major, Sickle Cell Disease, Spinal Muscular Atrophy, or Cystic Fibrosis). - Consanguinity: Marriage between blood relatives (first cousins, uncle-niece), which increases the probability of autosomal recessive genetic conditions. - Universal Thalassemia Screening: FOGSI recommends universal HPLC (High-Performance Liquid Chromatography) hemoglobin electrophoresis screening for all Indian women planning pregnancy, due to high carrier frequencies in Indian populations.

[!NOTE] When to seek fertility evaluation: If you have not conceived after 12 months of trying (age <35) or 6 months (age ≥35), or sooner with irregular cycles, prior ectopic pregnancy, or ≥2 miscarriages — see Deep Research Section 1 — Fertility basics and Section 2 — Infertility workup criteria. This guide covers workup timing, not a full ART/IUI/IVF treatment encyclopedia.

2. Preconception & Pregnancy Vaccination Matrix

Vaccinations protect the mother from severe infection and provide passive antibody protection to the newborn. The National Immunization Schedule (NIS) mandates routine Tetanus & Adult Diphtheria (Td) vaccination for all pregnant women. Other vaccines listed below represent preconception or indication-based protection recommended by FOGSI and clinical guidance:

3. High-Risk Pregnancy Framework & Preeclampsia Surveillance

In 2024, the Ministry of Health & Family Welfare expanded the Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA) high-risk pregnancy framework to 25 high-risk categories to ensure targeted specialist care.

Preeclampsia Risk Note: Women identified at high risk for preeclampsia (such as those with chronic hypertension, pre-existing diabetes, twin pregnancy, or prior preeclampsia) may be prescribed low-dose aspirin by their obstetrician starting in late Trimester 1 (weeks 12–16) to reduce the risk of early-onset preeclampsia. This is a clinician-directed preventive treatment.

4. Trimester 1 (Weeks 1–13) — Nutrition, Symptoms & Care

A. Symptom Management & FOGSI Guidance

1. Nausea & Vomiting (NVP): Affects ~70% of pregnancies.
2. Dietary: Small, frequent meals; dry toast or biscuit before rising; ginger tea. Avoid greasy/spicy foods.
3. Pharmacological: FOGSI Good Clinical Practice Recommendations support doctor-prescribed Doxylamine + Pyridoxine (Vitamin B6) for persistent symptoms.
4. Hyperemesis Gravidarum Warning: Inability to retain fluids for 24 hours, weight loss (>5%), or ketonuria requires emergency hospital IV hydration.
5. Fatigue & Breast Changes: Progesterone-induced. Prioritize 8–9 hours of sleep; wear supportive non-wired cotton brassieres.
6. Constipation: Increased dietary fiber (whole grains, dals, vegetables) and fluid intake.

B. Dietary & Environmental Safety (India-Specific)

• Calcium & Vitamin D: Dietary calcium target is often cited around ~1,000–1,200 mg/day from food + supplements combined. India’s NHM/FOGSI tablet schedule is typically 1,000 mg elemental calcium daily from week 14 (two 500 mg tablets) through pregnancy and 180 days postpartum — see Trimester 2 Master Schedule. Vitamin D is prescribed based on clinical evaluation and local screening.
• Vitamin B12: Critical for strict lacto-vegetarians and vegans; B12 supplementation is essential for fetal neurological development.
• Water Safety: Consume boiled or purified/RO water based on local municipal supply quality. Ensure drinking water containers are covered and cleaned daily.
• Food Hygiene: Boil raw milk thoroughly; avoid unpasteurized dairy, pre-cut street fruit, and raw unwashed salads.
• Fish & Mercury: Local Indian low-mercury fish (rohu, katla, pomfret, small freshwater fish) are nutritious sources of protein and omega-3s. Avoid large predatory fish (shark, swordfish, surmai/king mackerel) due to bioaccumulated mercury.
• Oral Health & Dental Care: Dental examination and routine cleaning are safe and encouraged during pregnancy. Treating active periodontal infection promotes general maternal health and comfort.
• Air Pollution & Mosquito Exposure: Wear N95 masks during high PM2.5 smog days in urban areas. Use pregnancy-safe mosquito repellents (DEET/Picaridin based) and bed nets to prevent Dengue and Malaria.

5. First Prenatal Visit & Antenatal Testing Checklist

The first antenatal visit (ideally before 10–12 weeks) establishes your baseline health profile:

6. Trimester 1 Warning Signs

[!CAUTION] Proceed immediately to hospital casualty/emergency if you experience: - Vaginal bleeding or bright red spotting (with or without abdominal pain). - Severe lower abdominal or pelvic pain (especially one-sided, which can indicate ectopic pregnancy). - Severe, unrelenting vomiting unable to retain water for 24 hours. - High fever (≥100.4°F / 38°C) or severe chills. - Leaking of watery fluid from vagina.

7. 📚 Recommended Reading

Patient Education & Resource Companion These resources are supplementary patient reading and do not replace Indian clinical guidance. Where recommendations differ, follow current MoHFW/NHM/FOGSI/ICOG/ICMR guidance and your clinician's advice.

• Must Read (Indian Patient-Facing Companion): Passport to a Healthy Pregnancy — Dr. Gita Arjun (2024 Westland edition) (Primary patient-facing companion written specifically for Indian couples, covering preconception through labour preparation).
• Optional International Reference: Your Pregnancy and Childbirth: Month to Month (7^th ed.) — ACOG (Comprehensive international clinical reference companion).

Clinical Source Metadata

• Clinical Content Status: Structural & content audit completed; selected high-risk clinical claims verified against current national guidance; full claim-by-claim clinical verification required before publication.
• Last Source Review: July 2026
• Primary Authority: Latest applicable Ministry of Health & Family Welfare (MoHFW) / National Health Mission (NHM) guidance
• Secondary Authorities: FOGSI / ICOG / ICMR-NIN and applicable condition-specific guidelines

← Previous Stage: Periods & Menstrual Health | Next Stage: Trimester 2 (Weeks 14–27) →